{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:50:45Z","timestamp":1786992645037,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jiph.2021.06.014","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T12:37:26Z","timestamp":1624624646000},"page":"1069-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lessons for and from the COVID-19 pandemic response \u2014 An appraisal of guidance for the public health management of Invasive Meningococcal Disease"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-952X","authenticated-orcid":false,"given":"Brianna R.","family":"Morello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne C.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2021.06.014_bib0005","series-title":"International exemplars of effective COVID-19 control","author":"Miller","year":"2020"},{"key":"10.1016\/j.jiph.2021.06.014_bib0010","series-title":"Coronavirus disease 2019 (COVID-19) CDNA national guidelines for public health units","author":"Communicable Diseases Network Australia","year":"2021"},{"issue":"7","key":"10.1016\/j.jiph.2021.06.014_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.vaccine.2020.12.080","article-title":"Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March\u2013September 2020","volume":"39","author":"Middeldorp","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jiph.2021.06.014_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-020-05241-9","article-title":"Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease","volume":"13","author":"Taha","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jiph.2021.06.014_bib0025","series-title":"Neisseria","article-title":"Mechanisms of cellular invasion of Neisseria meningitidis","author":"Carbonnelle","year":"2010"},{"issue":"Suppl. 2","key":"10.1016\/j.jiph.2021.06.014_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jiph.2021.06.014_bib0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.jiph.2021.06.014_bib0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","article-title":"Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Zunt","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.jiph.2021.06.014_bib0045","first-page":"1111","article-title":"Characterization of oropharyngeal carriage isolates of Neisseria meningitidis in healthy Korean adolescents in 2015","volume":"32","author":"Kim","year":"2017","journal-title":"JKMS"},{"issue":"1","key":"10.1016\/j.jiph.2021.06.014_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","author":"Jafri","year":"2013","journal-title":"Popul Health Metr"},{"issue":"2","key":"10.1016\/j.jiph.2021.06.014_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5694\/mja2.50481","article-title":"First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia","volume":"212","author":"Marshall","year":"2020","journal-title":"Med J Aust"},{"issue":"11","key":"10.1016\/j.jiph.2021.06.014_bib0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.apjtm.2017.10.004","article-title":"Meningococcal disease, a clinical and epidemiological review","volume":"10","author":"Batista","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.jiph.2021.06.014_bib0065","article-title":"First real world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease; prospective enhanced national surveillance, England","author":"Ladhani","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2021.06.014_bib0070","series-title":"Public health management of sporadic cases of invasive meningococcal disease and their contacts","author":"European Centre for Disease Prevention and Control","year":"2010"},{"key":"10.1016\/j.jiph.2021.06.014_bib0075","series-title":"Invasive meningococcal disease CDNA guidance for public health units","author":"Communicable Diseases Network Australia","year":"2017"},{"issue":"4","key":"10.1016\/j.jiph.2021.06.014_bib0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"issue":"18","key":"10.1016\/j.jiph.2021.06.014_bib0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jiph.2021.06.014_bib0090","series-title":"The AGREE II instrument [electronic version]","author":"AGREE Next Steps Consortium","year":"2009"},{"issue":"8","key":"10.1016\/j.jiph.2021.06.014_bib0095","doi-asserted-by":"crossref","first-page":"e38891","DOI":"10.1371\/journal.pone.0038891","article-title":"Appraisal of WHO guidelines in maternal health using the AGREE II assessment tool","volume":"7","author":"Polus","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiph.2021.06.014_bib0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009189","article-title":"Assessment of the quality and content of national and international guidelines on hypertensive disorders of pregnancy using the AGREE II instrument","volume":"6","author":"Bazzano","year":"2016","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.jiph.2021.06.014_bib0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0141076813486261","article-title":"Guidelines in cardiac clinical practice: evaluation of their methodological quality using the AGREE II instrument","volume":"106","author":"Sabharwal","year":"2013","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.jiph.2021.06.014_bib0110","article-title":"Pediatric asthma treatment: what to do when international guideline recommendations do not agree","volume":"121","author":"Linnemann","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jiph.2021.06.014_bib0115","series-title":"Guidelines for the prevention and control of meningococcal disease","author":"Public Health Agency of Canada","year":"2006"},{"key":"10.1016\/j.jiph.2021.06.014_bib0120","series-title":"Neisseria meningitidis invasive disease","author":"New Zealand Ministry of Health","year":"2018"},{"key":"10.1016\/j.jiph.2021.06.014_bib0125","series-title":"Manual for the surveillance of vaccine-preventable diseases","article-title":"Meningococcal disease","author":"MacNeil","year":"2011"},{"key":"10.1016\/j.jiph.2021.06.014_bib0130","series-title":"Guidance for public health management of meningococcal disease in the UK: updated February 2018","author":"Public Health England","year":"2018"},{"key":"10.1016\/j.jiph.2021.06.014_bib0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0163-4453(81)80009-6","article-title":"Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts","volume":"3","author":"De Wals","year":"1981","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jiph.2021.06.014_bib0140","first-page":"e58","article-title":"The epidemiology and management of clusters of invasive meningococcal disease in England, 2010\u201315","volume":"42","author":"Gobin","year":"2020","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.jiph.2021.06.014_bib0145","series-title":"Neisseria meningitidis: methods and protocols","first-page":"149","article-title":"Modeling Neisseria meningitidis infection in mice: methods and logistical considerations for nasal colonization and invasive disease","author":"Johswich","year":"2019"},{"key":"10.1016\/j.jiph.2021.06.014_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijid.2018.05.022","article-title":"Meningococcal carriage in high-risk settings: a systematic review","volume":"73","author":"Peterson","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2021.06.014_bib0155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/21645515.2018.1551672","article-title":"B Part of it study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia","volume":"15","author":"McMillan","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.jiph.2021.06.014_bib0160","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3201\/eid1206.051297","article-title":"Social behavior and meningococcal carriage in British teenagers","volume":"12","author":"Maclennan","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"43","key":"10.1016\/j.jiph.2021.06.014_bib0165","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6543a3","article-title":"Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons\u2014Advisory Committee on Immunization Practices, 2016","volume":"65","author":"MacNeil","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.jiph.2021.06.014_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2807\/1560-7917.ES.2016.21.5.30125","article-title":"European public health policies for managing contacts of invasive meningococcal disease cases better harmonised in 2013 than in 2007","volume":"21","author":"Vygen","year":"2016","journal-title":"Euro Surveill"},{"issue":"10","key":"10.1016\/j.jiph.2021.06.014_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2807\/ese.13.10.08060-en","article-title":"A European survey on public health policies for managing cases of meningococcal disease and their contacts","volume":"13","author":"Hoek","year":"2008","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jiph.2021.06.014_bib0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal carriage and disease\u2014population biology and evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jiph.2021.06.014_bib0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1017\/S0950268805005339","article-title":"The natural history of meningococcal carriage and disease","volume":"134","author":"Trotter","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.jiph.2021.06.014_bib0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhin.2020.07.023","article-title":"Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections","volume":"106","author":"Tan","year":"2020","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiph.2021.06.014_bib0195","first-page":"e67023","article-title":"Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.jiph.2021.06.014_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:09:12Z","timestamp":1761750552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034121001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1876034121001805"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2021.06.014","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons for and from the COVID-19 pandemic response \u2014 An appraisal of guidance for the public health management of Invasive Meningococcal Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2021.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}